Location: Home
  • search
  • go
  • Relate News
  • 6/1/2011New study highlights prevalence and therapeutic trends for diabetes in...
  • 6/1/2011Novo Nordisk to fend off competition by boosting China investments
  • 5/27/2011Park Nicollet launches Chinese diabetes care training project with San...
  • 5/17/2011India under pressure of growing API import from China
  • 5/12/2011China Initiative for Diabetes Excellence program launched with Sanofi ...
  • 3/23/2011Datamonitor: Chinese diabetes market to triple by 2019
  • 3/16/2011India pushes hard for better access to Chinese pharma market
  • 2/17/2011Market Snapshot - Leading Players of Chinese Diabetes Market
  • 2/11/2011Latest survey reveals high treatment costs of diabetes in China
  • 2/9/2011Takeda initiates clinical study of diabetes drug Alogliptin in China
  • 1/28/2011Will Asia's Insulin Makers Outperform Rivals in United States?
  • 1/12/2011Livzon claims victory in patent battle with India over bird flu herbal...
  • 12/29/2010Huadong Pharma acquires two diabetes drugs with CNY 25 million
  • 12/15/2010China and India to join hands to supply the global drug market
  • 12/1/2010New report: Chinese drug market for type II diabetes to reach US$2.5B ...
  • 11/22/2010Data Monitor: Chinese diabetes drug market to triple in next decade
  • 11/19/2010Cipla close to a global supply pact with Pfizer?
  • 11/18/2010CDS release survey of type II diabetes self-management by patients
  • 11/16/2010Pharma industry cooperation under discussion between leading Chinese a...
  • 11/15/2010China's diabetes prevalence and medical expenditures soar
  • 11/2/2010Eli Lilly establishes diabetes research center in Shanghai
  • 11/1/2010SFDA withdraws Sibutramine from the Chinese market
  • 10/26/2010Biocon eyes alternatives for Insugen after its China deal with Bayer t...
  • 10/25/2010PhRMA urges India for a better IP environment
  • 10/20/2010China initiates another major project for diabetes prevention and care
  • 10/18/2010China to keep Rosiglitazone on the market with conditions
  • 10/13/2010Chinese manufacturers of Sibutramine hang on to their products for now
  • 9/26/2010SFDA reviews ADRs of rosiglitazone-containing drugs after EMA and USFD...
  • 9/20/2010IMARC: the Chinese diabetes market to exceed US$ 2.8 Billion by 2015
  • 9/6/2010Bayer launches human recombinant insulin in China
  • Page:15/19 Total number of articles:544: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group